Presentation + Paper
10 October 2020 Heptamethine cyanine-based small molecular cancer theranostic agents
Author Affiliations +
Abstract
Cancer theranostic agents with a combination of cancer therapy and real-time imaging/diagnosis, provide a promising prospect for individualized and precise cancer treatment. Here, a series of structure-inherent multifunctional fluorescent small molecules, namely heptamethine cyanine dyes, were developed simultaneously for tumor-targeting, near-infrared imaging and therapy. Obtainment of cancer theranostic agents based on structure-inherent multifunctional small molecules, is a simple and straightforward way, and small molecules have advantages of easy, low-cost and large-scale synthesis, including good repeatability and quality control. Therefore, our findings may provide an alternative approach to develop multifunctional cancer theranostic agents.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Xie Huang and Shenglin Luo "Heptamethine cyanine-based small molecular cancer theranostic agents", Proc. SPIE 11553, Optics in Health Care and Biomedical Optics X, 115530T (10 October 2020); https://doi.org/10.1117/12.2573854
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Tumors

Molecules

Nanomaterials

Oncology

Clinical trials

Diagnostics

Back to Top